Elastrin Therapeutics

About

Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.

Simpsonville,South Carolina,United States
1 - 10
https://www.elastrin.com/

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $10M
Industries: Biopharma,Biotechnology,Therapeutics
Founded date: Jan 1, 2017
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: Elastrin Therapeutics, Inc.

Elastrin Therapeutics is a biotech startup with technologies to restore hardened and damaged arteries & tissue by targeting the elastic fiber that makes them work.

The company's proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$16.09M

Elastrin Therapeutics has raised a total of $16.09M in funding over 2 rounds. Their latest funding was raised on Apr 7, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Apr 7, 2022	Series Unknown	$10M	3	KIZOO Technology Capital	—	Detail
Mar 25, 2022	Series Unknown	$3.59M	—	—	—	Detail
Mar 4, 2021	Seed	$2.50M	1	KIZOO Technology Capital	—	Detail